Following a very competitive application process, the Fogarty Institute is excited to welcome four new startups to its incubator program: Healyx, palmm, Radial Medical and Raydiant Oximetry. The companies were selected based on their proven experience in the space, potential to develop innovative methods to serve unmet healthcare needs and interest in advancing our mission of transforming the industry.
The new startups join the Institute as two other companies, nVision Medical and InPress Technologies, graduate. Both companies have received funding and shown that their technologies have evolved sufficiently to allow the startups to move to their own facilities and operate independently. Seven companies have now successfully graduated since the Institute’s inception nearly 10 years ago.
“The application process was rigorous, and we are delighted to welcome these qualified companies, whose unique focuses support our goal to address a broad spectrum of patient needs,” said Andrew Cleeland, CEO of the Fogarty Institute. “We look forward to mentoring and educating them to help them thrive and make an impact – not only to solve specific healthcare needs, but to become financially successful entities that will offer a sustained impact. We believe they will be a strong addition to our growing roster of successful graduate companies.”
- Healyx is developing an innovative, cost-effective solution aimed at helping doctors in low-income countries successfully treat patients with severe wounds, with a device that improves on the highly regarded method of Negative Pressure Wound Therapy (NPWT).
In resource-constrained countries, non-healing wounds such as burns, trauma wounds, diabetic ulcers and pressure sores compound overcrowding in hospitals and place a significant expense on patients, driven by daily gauze dressing changes and hospital charges. The problem is immense: The incidence of open wounds exceeds 110 million patients worldwide and is growing due to an aging global population and increasing rates of diseases that cause chronic wounds.
Healyx was launched in 2015 as part of one of Stanford’s social innovation programs, Design for Extreme Affordability. The leadership team consists of co-founders Cam Hutton, CEO, and Madeline Sides, product lead.
